This Week's Poll

At the recent BioPartner Forum it was stated the internal market is insufficient for a UK Life Science company to develop a technology, product or service at a rate that will return investor value. Do you
Supported by Medilink UK

Support for Export - Federico Loterijman of - Anders Associates - 13:56:19pm Jul-29th

Our recent work with a couple of clients has meant we are more aware of the potential opportunities in India, especially for UK pharmaceutical consultancy & design expertise. Many global conglomerates have facilities in India and we’ve found making contact with the local Embassy is a good way of arranging relevant introductions. But accessing a market this geographically distant requires a financial investment, one that is often out of the reach of SMEs without some level of government support. The abolishment of the RDAs makes this a very concerning time for companies and their export strategies.
Agree/Disagree + add comment

Adam Maclean of - The Good Birth Company - 13:12:40pm Aug-9th

My feelings are mixed. I am always dubious about the value of going on one of these trips. However they do serve to raise awareness about opportunities in the destination country in the wider UK business community. The government absolutely has a role in opening up foreign markets - most obviously at the trade barriers level. The main issues in trading with India are high import fees/tarrifs/duties and restrictions on foreign ownership - if these can be brought down in the long term then great. They are improving already but it is slow progress.

Simon Checkley of - e-Medix - 14:25:09pm Jul-29th

Historically we’ve not considered India a commercially viable market because of their unwillingness to pay market rates, but we’ve recently started conversations with a company who may change our mind. Hopefully PM Cameron’s visit will be able to shift the focus from immigration and have some meaningful conversations about trade.
 
 
t